Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jun 24;6(2):ooad042. doi: 10.1093/jamiaopen/ooad042

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023. Published by Oxford University Press on behalf of the American Medical Informatics Association.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 5. — Relation of variables analyzed in the study relative to the total identified population of gender-expansive patients (dashed line; N = 2236) and those taking gender-affirming hormones (solid line; N = 1506). The bars depict the breakdown of how many patients were determined by chart review to be not gender-expansive, gender-expansive but not taking gender-affirming hormones, or gender-expansive and actively taking gender-affirming hormones. The individual bars include those with one or more SOGI field differences (excluding blank responses; N = 2298), those with at least 1 of 6 ICD-10 codes related to gender dysphoria for a clinical encounter (N = 1553), combination of SOGI field differences and/or ICD-10 codes related to gender dysphoria (N = 2422), and prescription for estradiol or testosterone suggesting use of gender-affirming hormones (eg, estradiol in someone with Legal Sex of “Male”; N = 1292).